Filing Details
- Accession Number:
- 0001209191-22-012878
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2022-02-24 19:55:23
- Reporting Period:
- 2020-12-08
- Accepted Time:
- 2022-02-24 19:55:23
- Original Submission Date:
- 2020-12-08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1671858 | Silverback Therapeutics Inc. | SBTX | Pharmaceutical Preparations (2834) | 811489190 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1831807 | Russ Hawkinson | C/O Silverback Therapeutics, Inc. 500 Fairview Avenue N, Suite 600 Seattle WA 98109 | Sr. Vice President Of Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-08 | 200 | $21.00 | 200 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The shares were purchased in the Issuer's initial public offering.
- On December 8, 2020, the reporting person filed a Form 4 in which he inadvertently reported a purchase of 238 shares of the issuer's common stock. In fact, as reported in this amendment, the reporting person purchased 200 shares of the issuer's common stock.
Billionaire Hedge Funds
